Literature DB >> 1862693

Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.

N al-Muhtaseb1, A R al-Yuosuf, J S Bajaj.   

Abstract

Plasma lipids, lipoproteins and apolipoproteins (apo) were analysed in 30 young Arab IDDM and 50 young insulin-requiring NIDDM women. The mean age of IDDM and NIDDM groups was 20.2 and 34.5 years, and mean duration of diabetes was 5.7 and 4.6 years, respectively. Two groups of 40 and 60 healthy women (matched for age and BMI) provided corresponding control groups. In comparison with control subjects, diabetics showed marked increases in the following parameters: total cholesterol (TC), low density lipoprotein (LDL) cholesterol, total triglycerides (TG), very low density lipoprotein (VLDL) triglycerides, phospholipids, apoB, LDL apoB, glucose and glycosylated hemoglobin (HbA1c) as well as the ratios of total cholesterol/high density lipoprotein (HDL) cholesterol, LDL-cholesterol/HDL-cholesterol, LDL cholesterol/high density lipoprotein (HDL) cholesterol, LDL-cholesterol/HDL-cholesterol, LDL cholesterol/high density lipoprotein 2 (HDL2) cholesterol and apoB/apoAI. Plasma LCAT activity, concentrations of HDL3 apoAI and apoAII in plasma and lipoprotein fractions were normal in both the diabetic groups. Levels of C-peptide, HDL, HDL2 and HDL3 cholesterol, plasma apoAI, HDL apoAI and HDL2 apoAI were markedly decreased in the diabetic groups as compared to their corresponding controls. There was no significant correlation between fasting glucose or HbA1c and any of the above parameters. Despite insulin therapy in both the diabetic groups studied, abnormalities in lipids, apoB and apoAI still persisted. Our data suggest a possible higher risk of atherosclerosis in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862693     DOI: 10.1007/bf02732115

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  38 in total

1.  Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment.

Authors:  M R Taskinen; E A Nikkilä
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

2.  Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study.

Authors:  M F Lopes-Virella; H J Wohltmann; R K Mayfield; C B Loadholt; J A Colwell
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

3.  High density lipoproteins in diabetes.

Authors:  E A Nikkilä
Journal:  Diabetes       Date:  1981       Impact factor: 9.461

4.  A community study of high density lipoproteins in adult noninsulin-dependent diabetics.

Authors:  E Barrett-Connor; J L Witztum; M Holdbrook
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

5.  Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients.

Authors:  J M Sosenko; J L Breslow; O S Miettinen; K H Gabbay
Journal:  N Engl J Med       Date:  1980-03-20       Impact factor: 91.245

6.  Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.

Authors:  M Laakso; E Voutilainen; H Sarlund; A Aro; K Pyörälä; I Penttilä
Journal:  Atherosclerosis       Date:  1985-09       Impact factor: 5.162

7.  Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?

Authors:  E A Nikkilä
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1985

8.  High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes.

Authors:  K G Taylor; A D Wright; T J Carter; A J Valente; S A Betts; K A Matthews
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

9.  Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control.

Authors:  B Gonen; N White; G Schonfeld; D Skor; P Miller; J Santiago
Journal:  Metabolism       Date:  1985-07       Impact factor: 8.694

10.  Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.

Authors:  G Schernthaner; G M Kostner; H Dieplinger; R Prager; I Mühlhauser
Journal:  Atherosclerosis       Date:  1983-12       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.